SCHEMBL4889485

SCHEMBL4889485

CS(=O)(=O)Nc1ccc2c(c1)c(-c1ccccc1)c(C(=O)O)n2C(c1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.48
PLA2G4A P47712 4/20 0.47
ACLY P53396 1/20 0.40
MAPK8 P45983 1/20 0.40
MET P08581 2/20 0.39
KCNH2 Q12809 1/20 0.39
PHGDH O43175 1/20 0.38
KDM4E B2RXH2 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4890995 0.88 SERPINE1 (0.63) SERPINE1PLA2G4AACLY
SCHEMBL4884301 0.77 SERPINE1 (0.80) SERPINE1MAPK8
SCHEMBL4891950 0.70 SERPINE1 (0.71) SERPINE1
SCHEMBL5424000 0.68 SERPINE1 (0.62) SERPINE1MAPK8KDM4E
SCHEMBL22004380 0.67 ACLY (0.58) PLA2G4AACLYMAPK8KDM4E
SCHEMBL4887004 0.65 SERPINE1 (1.00) SERPINE1MAPK8
SCHEMBL4892537 0.65 SERPINE1 (1.00) SERPINE1MAPK8
SCHEMBL28111698 0.65 KEAP1 (0.58)
SCHEMBL6500176 0.64 SMN1; SMN2 (0.55) KDM4E
SCHEMBL28012269 0.62 ALDH1A1 (0.57) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES WYETH (US) 2008-12-25 US claimed
JP-2007506769-A 2007-03-22 JP claimed
EP-1667969-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS Wyeth (US) 2006-06-14 EP claimed
US-20050096377-A1 Substituted sulfonamide-indoles WYETH (US) 2005-05-05 US claimed
WO-2005030715-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS WYETH (US) 2005-04-07 WO claimed
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES WYETH (US) 2008-12-25 US disclosed
US-7442805-B2 Substituted sulfonamide-indoles WYETH (US) 2008-10-28 US disclosed
EP-1667969-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS Wyeth (US) 2006-06-14 EP disclosed
US-20050096377-A1 Substituted sulfonamide-indoles WYETH (US) 2005-05-05 US disclosed
WO-2005030715-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS WYETH (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES STS, TPST2, IDO2 SERPINE1 4706/4885PLA2G4A 2542/4885ACLY 2169/4885
US-20050096377-A1 Substituted sulfonamide-indoles STS, TPST2, IDO2 SERPINE1 4706/4885PLA2G4A 2542/4885ACLY 2169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.